Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05522972 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Establishing New Treatment Approaches for Amblyopia: Perceptual Learning and Video Games

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Re-verified, no change to tracked fieldsv5
  2. Notable Primary and study completion dates: Aug 31, 2028 to Aug 31, 2029
    • Publications: 11 to 12
    v4
  3. Notable Enrollment target: 90 to 180
    • Primary completion date: Aug 31, 2026 to Aug 31, 2028
    • Publications: 10 to 11
    v3
  4. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Sep 1, 2022 to Sep 13, 2022
    • Site details revised
    v2
  5. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Amblyopia, a developmental abnormality that impairs spatial vision, is a major cause of vision loss, resulting in reduced visual acuity and reduced sensitivity to contrast. This study uses psychophysical measures to study neural plasticity in both adults and children with amblyopia.
Trial Details
NCT Number NCT05522972
Lead Sponsor Nova Southeastern University
Conditions
(from sponsor)
Amblyopia
Related terms Amblyopia, Strabismus
Enrollment 180 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov